This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Biomerieux Sa, Biomerieux, Inc.. Active years: 2013-2016.
Location History:
- Oisterwijk, NL (2013 - 2014)
- Olsterwijk, NL (2016)
Company Filing History:
Years Active: 2013-2016
Title: Birgit Deiman: Innovator in Nucleic Acid Amplification and Bacterial Detection
Introduction
Birgit Deiman is a prominent inventor based in Oisterwijk, Netherlands. She has made significant contributions to the field of medical diagnostics, particularly in the detection of methicillin-resistant bacteria. With a total of 3 patents to her name, her work has had a substantial impact on improving testing methods in healthcare.
Latest Patents
One of her latest patents focuses on providing improved tests for the detection of methicillin-resistant bacteria. This invention is particularly useful for eliminating false positive results that may arise due to the presence of a mixed bacterial population in patient samples. Another notable patent involves multiplex nucleic acid amplification using blocked primers. This invention enhances transcription-based amplification, offering improved primers and methods that optimize multiplex reactions.
Career Highlights
Throughout her career, Birgit has worked with notable companies such as bioMérieux SA and bioMérieux, Inc. Her expertise in the field has allowed her to develop innovative solutions that address critical challenges in medical diagnostics.
Collaborations
Birgit has collaborated with esteemed colleagues, including Dianne Van Strijp and Corinne Jay. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Birgit Deiman's contributions to the field of medical diagnostics through her innovative patents demonstrate her commitment to improving healthcare outcomes. Her work continues to influence the development of more accurate testing methods for bacterial detection.